Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 31 Jan 2018 for REPROS THERAPEUTICS INC., €12k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Michael Wyllie: trading record in brief
This profile gathers the share dealings of Michael Wyllie in Repros Therapeutics Inc. Over a trading history stretching from 12 September 2012 to 31 January 2018, the count stands at 7 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 31 January 2018 with a transaction (€12k) in Repros Therapeutics Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael Wyllie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
21,580 shares@ US$0.6743.7% of flowCommon StockSEC:0001144204-18-004789:0
27,779 shares@ US$0.6756.3% of flowCommon StockSEC:0001144204-18-004789:1
40,000 sharesCommon StockSEC:0001144204-17-009375:0
3,333 shares@ US$4.43Common StockSEC:0001533834-12-000004:0
1,068 shares@ US$13.83Common StockSEC:0001533834-12-000004:1
9,999 shares@ US$4.43Common StockSEC:0001533834-12-000001:0
2,905 shares@ US$15.25Common StockSEC:0001533834-12-000001:1
7 of 7 declarations
